| James Earl Genobaga, DDS | |
|
367 Del Norte Ave, Suite 1, Yuba City, CA 95991-4116 | |
| (530) 763-4231 | |
| (530) 763-4316 |
| Full Name | James Earl Genobaga |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 367 Del Norte Ave, Yuba City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285687715 | NPI | - | NPPES |
| 146333 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 4387 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Earl Genobaga, DDS 367 Del Norte Ave, Suite 1, Yuba City, CA 95991-4116 Ph: (530) 763-4231 | James Earl Genobaga, DDS 367 Del Norte Ave, Suite 1, Yuba City, CA 95991-4116 Ph: (530) 763-4231 |
News Archive
Drexel University has received a grant for a five-year study of medical marijuana and its impact on drug use and physical and psychological health among young adults in Los Angeles. It is the first large-scale NIH project funded to directly investigate medical marijuana use among young adults aged 18 to 26.
The first close-up look at a pro-inflammatory signaling molecule involved in immune response in mammals suggests that researchers "should rethink what they are doing" in creating drugs based on a fruit-fly model, scientists say.
The Journal of Neurosurgery (JNS) Publishing Group is proud to announce publication of the NACTN/AOSNA Focus Issue on Spinal Cord Injury, a supplement to the September issue of the Journal of Neurosurgery: Spine, which is sponsored by AOSpine North America available in print and online.
An alliance of institutions collectively managing an estimated 80 percent of all public health research funding worldwide today announced their first targets for concerted action in the fight against "chronic non-communicable diseases" (CNCDs).
A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.
› Verified 8 days ago
Navneet Shergill, Dentist Medicare: Not Enrolled in Medicare Practice Location: 415 Alturas St, Yuba City, CA 95991 Phone: 916-722-4900 | |
Dr. Patricia Bezad, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 1054 Harter Rd., #5, Yuba City, CA 95993 Phone: 916-749-0990 Fax: 530-755-9887 | |
Flordeliza D Flores, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1408 Live Oak Blvd, Suite C, Yuba City, CA 95991 Phone: 530-742-0388 Fax: 530-742-0736 | |
Dr. Petr Kadera, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 871 Gray Ave, Suite B, Yuba City, CA 95991 Phone: 530-763-3222 Fax: 844-534-8464 | |
Jaspreet Singh Dhami, Dentist Medicare: Medicare Enrolled Practice Location: 727 Colusa Ave, Yuba City, CA 95991 Phone: 530-216-5022 | |
Dr. Sukhpreet Kaur Heer, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1892 Marjorie Dr, Yuba City, CA 95993 Phone: 530-300-2671 | |
Dr. Paramjit Singh Everest, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1045 Live Oak Blvd, Suite #a, Yuba City, CA 95991 Phone: 530-673-6565 |